NM_014608.6:c.3603G>A
Variant names:
Variant summary
Our verdict is Benign. The variant received -16 ACMG points: 1P and 17B. PP3BP6_Very_StrongBP7BS1BS2
The NM_014608.6(CYFIP1):c.3603G>A(p.Leu1201Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00192 in 1,609,202 control chromosomes in the GnomAD database, including 53 homozygotes. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0091 ( 21 hom., cov: 33)
Exomes 𝑓: 0.0012 ( 32 hom. )
Consequence
CYFIP1
NM_014608.6 synonymous
NM_014608.6 synonymous
Scores
1
1
Clinical Significance
Conservation
PhyloP100: 1.77
Publications
1 publications found
Genes affected
CYFIP1 (HGNC:13759): (cytoplasmic FMR1 interacting protein 1) This gene encodes a protein that regulates cytoskeletal dynamics and protein translation. The encoded protein is a component of the WAVE regulatory complex (WRC), which promotes actin polymerization. This protein also interacts with the synaptic functional regulator FMR1 protein and translation initiation factor 4E to inhibit protein translation. A large chromosomal deletion including this gene is associated with increased risk of schizophrenia and epilepsy in human patients. Reduced expression of this gene has been observed in various human cancers and the encoded protein may inhibit tumor invasion. [provided by RefSeq, Mar 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -16 ACMG points.
PP3
BayesDel_noAF computational evidence supports a deleterious effect, 0.26
BP6
Variant 15-22870187-C-T is Benign according to our data. Variant chr15-22870187-C-T is described in ClinVar as [Benign]. Clinvar id is 781719.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00905 (1379/152328) while in subpopulation AFR AF = 0.0303 (1260/41566). AF 95% confidence interval is 0.0289. There are 21 homozygotes in GnomAd4. There are 642 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 21 gene
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00905 AC: 1377AN: 152210Hom.: 21 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
1377
AN:
152210
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00267 AC: 656AN: 246036 AF XY: 0.00213 show subpopulations
GnomAD2 exomes
AF:
AC:
656
AN:
246036
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00117 AC: 1711AN: 1456874Hom.: 32 Cov.: 31 AF XY: 0.00104 AC XY: 756AN XY: 724666 show subpopulations
GnomAD4 exome
AF:
AC:
1711
AN:
1456874
Hom.:
Cov.:
31
AF XY:
AC XY:
756
AN XY:
724666
show subpopulations
African (AFR)
AF:
AC:
1027
AN:
33124
American (AMR)
AF:
AC:
98
AN:
43694
Ashkenazi Jewish (ASJ)
AF:
AC:
179
AN:
26058
East Asian (EAS)
AF:
AC:
0
AN:
39300
South Asian (SAS)
AF:
AC:
4
AN:
85160
European-Finnish (FIN)
AF:
AC:
1
AN:
53384
Middle Eastern (MID)
AF:
AC:
15
AN:
5754
European-Non Finnish (NFE)
AF:
AC:
207
AN:
1110156
Other (OTH)
AF:
AC:
180
AN:
60244
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
76
152
227
303
379
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00905 AC: 1379AN: 152328Hom.: 21 Cov.: 33 AF XY: 0.00862 AC XY: 642AN XY: 74488 show subpopulations
GnomAD4 genome
AF:
AC:
1379
AN:
152328
Hom.:
Cov.:
33
AF XY:
AC XY:
642
AN XY:
74488
show subpopulations
African (AFR)
AF:
AC:
1260
AN:
41566
American (AMR)
AF:
AC:
36
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
38
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5186
South Asian (SAS)
AF:
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
AC:
29
AN:
68034
Other (OTH)
AF:
AC:
15
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
68
135
203
270
338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Pathogenic
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.